Clinical outcomes and predictors of maternal and fetal complications in pregnancies of patients with systemic lupus erythematosus

References

• Knight CL, Nelson-Piercy C. Management of systemic lupus erythematosus during pregnancy: challenges and solutions. Open Access Rheumatol. 2017;9:37–53.
   PubMed Web of Science ®Google Scholar
• Jordan N. Management of pregnancy in systemic lupus erythematosus: what a GP should know. Lupus. 2018;27:40–43.
   PubMed Web of Science ®Google Scholar
• Rees F, Doherty M, Grainge MJ, et al. The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies. Rheumatology. 2017;56:1945–1961.
   PubMed Web of Science ®Google Scholar
• Tedeschi SK, Bermas B, Costenbader KH. Sexual disparities in the incidence and course of SLE and RA. Clin Immunol. 2013;149:211–218.
   PubMed Web of Science ®Google Scholar
• Wu J, Ma J, Zhang WH, et al. Management and outcomes of pregnancy with or without lupus nephritis: a systematic review and meta-analysis. Ther Clin Risk Manag. 2018;14:885–901.
   PubMed Web of Science ®Google Scholar
• Lazzaroni MG, Dall‘Ara F, Fredi M, et al. A comprehensive review of the clinical approach to pregnancy and systemic lupus erythematosus. J Autoimmun. 2016;74:106–117.
   PubMed Web of Science ®Google Scholar
• Rahman A, Isenberg DA. Systemic lupus erythematosus. N Engl J Med. 2008;358:929–939.
   PubMed Web of Science ®Google Scholar
• Clark CA, Spitzer KA, Laskin CA. Decrease in pregnancy loss rates in patients with systemic lupus erythematosus over a 40-year period. J Rheumatol. 2005;32:1709–1712.
   PubMed Web of Science ®Google Scholar
• Andreoli L, Bertsias GK, Agmon-Levin N, et al. EULAR recommendations for women‘s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. Ann Rheum Dis. 2017;76:476–485.
   PubMed Web of Science ®Google Scholar
• Yamamoto Y, Aoki S. Systemic lupus erythematosus: strategies to improve pregnancy outcomes. Int J Womens Health. 2016;8:265–272.
   PubMed Web of Science ®Google Scholar
• Moroni G, Ponticelli C. Pregnancy in women with systemic lupus erythematosus (SLE). Eur J Intern Med. 2016;32:7–12.
   PubMed Web of Science ®Google Scholar
• Buyon JP, Kim MY, Guerra MM, et al. Predictors of pregnancy outcomes in patients with lupus: A cohort study. Ann Intern Med. 2015;163:153–163.
   PubMed Web of Science ®Google Scholar
• Chen D, Lao M, Zhang J, et al. Fetal and maternal outcomes of planned pregnancy in patients with systemic lupus erythematosus: a retrospective multicenter study. J Immunol Res. 2018;2018:2413637.
   PubMedGoogle Scholar
• Lateef A, Petri M. Systemic Lupus Erythematosus and Pregnancy. Rheum Dis Clin North Am. 2017;43:215–226.
   PubMed Web of Science ®Google Scholar
• American college of obstetricians and gynecologists. Task force on hypertension in pregnancy. Hypertension in pregnancy. Report of the American college of obstetricians and gynecologists’ task force on hypertension in pregnancy. Obstet Gynecol. 2013;122:1122–1131.
   PubMed Web of Science ®Google Scholar
• Fischer-Betz R, Specker C. Pregnancy in systemic lupus erythematosus and antiphospholipid syndrome. Best Pract Res Clin Rheumatol. 2017;31:397–414.
   PubMed Web of Science ®Google Scholar
• Borella E, Lojacono A, Gatto M, et al. Predictors of maternal and fetal complications in SLE patients: a prospective study. Immunol Res. 2014;60:170–176.
   PubMed Web of Science ®Google Scholar
• Julkunen H. Renal lupus in pregnancy. Scand J Rheumatol Suppl. 1998;107:80–83.
   PubMedGoogle Scholar
• Salmon JE, Heuser C, Triebwasser M, et al. Mutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohort. PLoS Med. 2011;8:e1001013.
   PubMed Web of Science ®Google Scholar
• Moroni G, Doria A, Giglio E, et al. Maternal outcome in pregnant women with lupus nephritisA prospective multicenter study. J Autoimmun. 2016;74:194–200.
   PubMed Web of Science ®Google Scholar
• Smyth A, Oliveira GHM, Lahr BD, et al. A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin J Am Soc Nephrol. 2010;5:2060–2068.
   PubMed Web of Science ®Google Scholar
• Kwok LW, Tam LS, Zhu TY, et al. Predictors of maternal and fetal outcomes in pregnancies of patients with systemic lupus erythematosus. Lupus. 2011;20:829–836.
   PubMed Web of Science ®Google Scholar
• Lateef A, Petri M. Managing lupus patients during pregnancy. Best Pract Res Clin Rheumatol. 2013;27:435–447.
   PubMed Web of Science ®Google Scholar
• Hutcheon JA, Lisonkova S, Joseph KS. Epidemiology of pre-eclampsia and the other hypertensive disoerders of pregnancy. Best Pract Res Clin Obstet Gynaecol. 2011;25:391–403.
   PubMed Web of Science ®Google Scholar
• Mbah AK, Alio AP, Marty PJ, et al. Pre-eclampsia in the first pregnancy and subsequent risk of stillbirth in black and white gravidas. Eur J Obstet Gynecol Reprod Biol. 2010;149:165–169.
   PubMed Web of Science ®Google Scholar
• Le Thi Huong D, Wechsler B, Piette JC. Pregnancy and systemic lupus erythematosus. Rev Med Interne. 2008;29:725–730.
   PubMed Web of Science ®Google Scholar
• Tedeschi SK, Massarotti E, Guan H, et al. Specific systemic lupus erythematosus disease manifestations in the six months prior to conception are associated with similar disease manifestations during pregnancy. Lupus. 2015;24:1283–1292.
   PubMed Web of Science ®Google Scholar
• Clowse ME, Magder LS, Witter F, et al. The impact of increased lupus activity on obstetric outcomes. Arthritis Rheumatism. 2005;52:514–521.
   PubMed Web of Science ®Google Scholar
• Moroni G, Ponticelli C. The risk of pregnancy in patients with lupus nephritis. J Nephrol. 2003;16:161–167.
   PubMed Web of Science ®Google Scholar
• Imbasciati E, Tincani A, Gregorini G, et al. Pregnancy in women with pre-existing lupus nephritis: predictors of fetal and maternal outcome. Nephrol Dial Transplant. 2009;24:519–525.
   PubMed Web of Science ®Google Scholar
• Saavedra MA, Sanchez A, Morales S, et al. Primigravida is associated with flare in women with systemic lupus erythematosus. Lupus. 2015;24:180–185.
   PubMed Web of Science ®Google Scholar
• Bramham K, Hunt BJ, Bewley S, et al. Pregnancy outcomes in systemic lupus erythematosus with and without previous nephritis. J Rheumatol. 2011;38:1906–1913.
   PubMed Web of Science ®Google Scholar
• Kroese SJ, Abheiden CNH, Blomjous BS, et al. Maternal and perinatal outcome in women with systemic lupus erythematosus: a retrospective bicenter cohort study. J Immunol Res. 2017;2017:8245879.
   PubMedGoogle Scholar
• Clowse ME, Jamison M, Myers E, et al. A national study of the complications of lupus in pregnancy. Am J Obstet Gynecol. 2008;199:127. e1–6
   PubMed Web of Science ®Google Scholar
• Clowse ME, Grotegut C. Racial and ethnic disparities in the pregnancies of women with systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2016;68:1567–1572.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Almaraz ME, Herraiz I, Gómez-Arriaga PI, et al. The role of angiogenic biomarkers and uterine artery doppler in pregnant women with systemic lupus erythematosus or antiphospholipid syndrome. Pregnancy Hypertens. 2018;11:99–104.
   PubMed Web of Science ®Google Scholar
• Soh MC, Nelson-Piercy C. Biomarkers for adverse pregnancy outcomes in rheumatic diseases. Rheum Dis Clin North Am. 2017;43:201–214.
   PubMed Web of Science ®Google Scholar
• Kim MY, Buyon JP, Guerra MM, et al. Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study. Am J Obstet Gynecol. 2016;214:108.
   PubMed Web of Science ®Google Scholar
• Larsson A, Palm M, Helmersson J, et al. Pentraxin 3 values during normal pregnancy. Inflammation. 2011;34:448–451.
   PubMed Web of Science ®Google Scholar
• Cruciani L, Romero R, Vaisbuch E, et al. Pentraxin 3 in amniotic fluid: a novel association with intra-amniotic infection and inflammation. J Perinatal Med. 2010;38:161–171.
   PubMed Web of Science ®Google Scholar
• Akolekar R, Casagrandi D, Livanos P, et al. Maternal plasma pentraxin 3 at 11 to 13 weeks of gestation in hypertensive disorders of pregnancy. Prenat Diagn. 2009;29:934–938.
   PubMed Web of Science ®Google Scholar
• Bassi N, Del Prete D, Ghirardello A, et al. PTX3, Anti-PTX3, and Anti-C1q autoantibodies in lupus glomerulonephritis. Clin Rev Allergy Immunol. 2015;49:217–226.
   PubMed Web of Science ®Google Scholar
• Gatto M, Ghirardello A, Luisetto R, et al. Immunisation with pentraxin 3 (PTX3) leads to anti-PTX3 antibody production and delayed lupus-like nephritis in NZB/NZW F1 mice. J Autoimmun. 2016;74:208–216.
   PubMed Web of Science ®Google Scholar
• Moroni G, Ponticelli C. Important considerations in pregnant patients with lupus nephritis. Expert Rev Clin Immunol. 2018;14:489–498.
   PubMed Web of Science ®Google Scholar
• Tufano A, Coppola A, Maruotti GM, et al. HELLP syndrome and its relation with the antiphospholipid syndrome. Blood Transfus. 2014;12:114–118.
   PubMed Web of Science ®Google Scholar
• Rahman FZ, Rahman J, Al-Suleiman SA, et al. Pregnancy outcome in lupus nephropathy. Arch Gynecol Obstet. 2005;271:222–226.
   PubMedGoogle Scholar
• Kongwattanakul K, Saksiriwuttho P, Chaiyarach S, et al. Incidence, characteristics, maternal complications, and perinatal outcomes associated with preeclampsia with severe features and HELLP syndrome. Int J Womens Health. 2018;10:371–377.
   PubMed Web of Science ®Google Scholar
• Klemmensen AK, Olsen SF, Wengel CM, et al. Diagnostic criteria and reporting procedures for pre-eclampsia: a national survey among obstetrical departments in Denmark. Eur J Obstet Gynecol Reprod Biol. 2005;123:41–45.
   PubMed Web of Science ®Google Scholar
• Lin LT, Wang PH, Tsui KH, et al. Increased risk of systemic lupus erythematosus in pregnancy-induced hypertension: A nationwide population-based retrospective cohort study. Medicine (Baltimore). 2016;95:e4407.
   PubMed Web of Science ®Google Scholar
• Ponticelli C, Moroni G. Flares in lupus nephritis: incidence, impact on renal survival and management. Lupus. 1998;7:635–638.
   PubMed Web of Science ®Google Scholar
• Tavakolpour S, Rahimzadeh G. New Insights into the Management of Patients with Autoimmune Diseases or Inflammatory Disorders During Pregnancy. Scand J Immunol. 2016;84:146–149.
   PubMed Web of Science ®Google Scholar
• Jara LJ, Medina G, Saavedra MA, et al. Prolactin has a pathogenic role in systemic lupus erythematosus. Immunol Res. 2017;65:512–523.
   PubMed Web of Science ®Google Scholar
• Jara LJ, Medina G, Cruz-Dominguez P, et al. Risk factors of systemic lupus erythematosus flares during pregnancy. Immunol Res. 2014;60:184–192.
   PubMed Web of Science ®Google Scholar
• Jara-Quezada L, Graef A, Lavalle C. Prolactin and gonadal hormones during pregnancy in systemic lupus erythematosus. J Rheumatol. 1991;18:349–353.
   PubMed Web of Science ®Google Scholar
• Doria A, Cutolo M, Ghirardello A, et al. Steroid hormones and disease activity during pregnancy in systemic lupus erythematosus. Arthritis Rheum. 2002;47:202–209.
   PubMed Web of Science ®Google Scholar
• Qian Q, Liuqin L, Hao L, et al. The effects of bromocriptine on preventing postpartum flare in systemic lupus erythematosus patients from South China. J Immunol Res. 2015;2015:316965.
   PubMedGoogle Scholar
• Leaños-Miranda A, Cárdenas-Mondragón G. Serum free prolactin concentrations in patients with systemic lupus erythematosus are associated with lupus activity. Rheumatology (Oxford). 2006;45:97–101.
   PubMed Web of Science ®Google Scholar
• Yang XY, Liang LQ, Xu HS, et al. Efficacy of oral bromocriptine in protecting the postpartum systemic lupus erythematosus patients from disease relapse. Zhonghua Nei Ke Za Zhi. 2003;42:621–624.
   PubMedGoogle Scholar
• Jara LJ, Cruz-Cruz P, Saavedra MA, et al. Bromocriptine during pregnancy in systemic lupus erythematosus: a pilot clinical trial. Ann N Y Acad Sci. 2007;1110:297–304.
   PubMed Web of Science ®Google Scholar
• Kim SY, Lee JH. Prognosis of neonates in pregnant women with systemic lupus erythematosus. Yonsei Med J. 2008;49:515–520.
   PubMed Web of Science ®Google Scholar
• Zhao C, Zhao J, Huang Y, et al. New-onset systemic lupus erythematosus during pregnancy. Clin Rheumatol. 2013;32:815–822.
   PubMed Web of Science ®Google Scholar
• Rodrigues BC, Lacerda MI, Ramires de Jesús GR, et al. The impact of different classes of lupus nephritis on maternal and fetal outcomes: a cohort studyof 147 pregnancies. Lupus. 2019;8:492–500.
   Web of Science ®Google Scholar
• Bassi N, Ghirardello A, Blank M, et al. IgG anti-pentraxin 3 antibodies in systemic lupus erythematosus. Ann Rheum Dis. 2010;69:1704–1710.
   PubMed Web of Science ®Google Scholar
• Ritchie J, Smyth A, Tower C, et al. Maternal deaths in women with lupus nephritis: a review of published evidence. Lupus. 2012; 21: 534–541.
   Google Scholar
• Bundhun PK, Soogund MZS, Huang F. Arterial/venous thrombosis, fetal loss and stillbirth in pregnant women with systemic lupus erythematosus versus primary and secondary antiphospholipid syndrome: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2018;18:212.
   PubMed Web of Science ®Google Scholar
• Danowski A, de Azevedo MN, de Souza Papi JA, et al. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus. J Rheumatol. 2009;36:1195–1199.
   PubMed Web of Science ®Google Scholar
• Fredi M, Andreoli L, Aggogeri E, et al. Risk factors for adverse maternal and fetal outcomes in women with confirmed apl positivity: results from a multicenter study of 283 pregnancies. Front Immunol. 2018;9:864.
   PubMed Web of Science ®Google Scholar
• Bundhun PK, Soogund MZ, Huang F. Impact of systemic lupus erythematosus on maternal and fetal outcomes following pregnancy: A meta-analysis of studies published between years 2001-2016. J Autoimmun. 2017;79:17–27.
   PubMed Web of Science ®Google Scholar
• Bender Ignacio RA, Madison AT, Moshiri A, et al. A population-based study of perinatal infection risk in women with and without systemic lupus erythematosus and their infants. Paediatr Perinat Epidemiol. 2018;32:81–89.
   PubMed Web of Science ®Google Scholar
• Moroni G, Doria A, Giglio E, et al. Fetal outcome and recommendations of pregnancies in lupus nephritis in the 21st century A prospective multicenter study. J Autoimmun. 2016;74:6–12.
   PubMed Web of Science ®Google Scholar
• Nahal SK, Selmi C, Gershwin ME. Safety issues and recommendations for successful pregnancy outcome in systemic lupus erythematosus. J Autoimmun. 2018;93:16–23.
   PubMed Web of Science ®Google Scholar
• Marder W, Littlejohn EA, Somers EC. Pregnancy and autoimmune connective tissue diseases. Best Pract Res Clin Rheumatol. 2016;30:63–80.
   PubMed Web of Science ®Google Scholar
• Chakravarty EF, Nelson L, Krishnan E. Obstetric hospitalizations in the United States for women with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum. 2006;54:899–907.
   PubMed Web of Science ®Google Scholar
• Gladman DD, Tandon A, Ibañez D, et al. The effect of lupus nephritis on pregnancy outcome and fetal and maternal complications. J Rheumatol. 2010;37:754–758.
   PubMed Web of Science ®Google Scholar
• Zhan Z, Zhan Y, Lao M, et al. Role of foetal umbilical artery Doppler on prediction of adverse pregnancy outcomes in patients with systemic lupus erythematosus. Clin Exp Rheumatol. 2018;36:871–878.
   PubMed Web of Science ®Google Scholar
• Physical status: the use and interpretation of anthropometry. Report of a WHO expert committee. World Health Organ Tech Rep Ser. 1995;854:1–452.
   PubMed Web of Science ®Google Scholar
• Deguchi M, Maesawa Y, Kubota S, et al. Factors associated with adverse pregnancy outcomes in women with systematic lupus erythematosus. J Reprod Immunol. 2018;125:39–44.
   PubMed Web of Science ®Google Scholar
• Clowse ME, Wallace DJ, Weisman M, et al. Predictors of preterm birth in patients with mild systemic lupus erythematosus, Annal. Rheum Dis. 2013;72:1536–1539.
   PubMed Web of Science ®Google Scholar
• Clark CA, Spitzer KA, Nadler JN, et al. Preterm deliveries in women with systemic lupus erythematosus. J Rheumatol. 2003;30:2127–2132.
   PubMed Web of Science ®Google Scholar
• Clowse ME, Magder LS, Witter F, et al. Early risk factors for pregnancy loss in. LupusObstet Gynecol. 2006;107:293–299.
   PubMed Web of Science ®Google Scholar
• Guettrot-Imbert G, Le Guern V, Morel N, et al. Systemic lupus erythematosus and antiphospholipid syndrome: how to manage pregnancy? Rev Med Interne. 2015;36:173–181.
   PubMed Web of Science ®Google Scholar
• Kim MY, Guerra MM, Kaplowitz E, et al. Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid antibodies. Ann Rheum Dis. 2018;77:549–555.
   PubMed Web of Science ®Google Scholar
• Yan Yuen S, Krizova A, Ouimet JM, et al. Pregnancy outcome in systemic lupus erythematosus (SLE) is improving: results from a case control study and literature review. Open Rheumatol J. 2008;2:89–98.
   PubMedGoogle Scholar
• Kaplowitz ET, Ferguson S, Guerra M, et al. Contribution of socioeconomic status to racial/ethnic disparities in adverse pregnancy outcomes among women with systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2018;70:230–235.
   PubMed Web of Science ®Google Scholar
• Bertolaccini ML, Atsumi T, Koike T, et al. Antiprothrombin antibodies detected in two different assay systems prevalence and clinical significance in systemic lupus erythematosus. Thromb Haemost. 2005;93:289–297.
   PubMed Web of Science ®Google Scholar
• Wu J, Zhang WH, Ma J, et al. Prediction of fetal loss in Chinese pregnant patients with systemic lupus erythematosus: a retrospective cohort study. BMJ Open. 2019;9:e023849.
   PubMedGoogle Scholar
• Tonello M, Hoxha A, Mattia E, et al. Low titer, isolated anti Ro/SSA 60Kd antibodies is correlated with positive pregnancy outcomes in women at risk of congenital heart block. Clin Rheumatol. 2017;36:1155–1160.
   PubMed Web of Science ®Google Scholar
• Tonello M, Ruffatti A, Favaro M, et al. Maternal autoantibody profiles at risk for autoimmune congenital heart block: a prospective study in high-risk patients. Lupus Sci Med. 2016;3:e000129.
   PubMed Web of Science ®Google Scholar
• Morel N, Lévesque K, Maltret A, et al. Incidence, risk factors, and mortality of neonatal and late-onset dilated cardiomyopathy associated with cardiac neonatal lupus. Int J Cardiol. 2017;248:263–269.
   PubMed Web of Science ®Google Scholar
• Levesque K, Morel N, Maltret A, et al. Description of 214 cases of autoimmune congenital heart block: results of the french neonatal lupus syndrome. Autoimmun Rev. 2015;14:1154–1160.
   PubMed Web of Science ®Google Scholar
• Izmirly PM, Costedoat-Chalumeau N, Pisoni CN, et al. Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupus. Circulation. 2012;126:76–82.
   PubMed Web of Science ®Google Scholar
• Preventive Approach to Congenital Heart Block With Hydroxychloroquine (PATCH) ClinicalTrials.gov Identifier: NCT01379573.
   Google Scholar
• Silverman E, Jaeggi E. Non-cardiac manifestations of neonatal lupus erythematosus. Scand J Immunol. 2010;72:223–225.
   PubMed Web of Science ®Google Scholar
• Sheth AP, Esterly NB, Ratoosh SL. U1RNP positive neonatal lupus erythematosus: association with anti-La antibodies?. Br J Dermatol. 1995;132:520–526.
   PubMed Web of Science ®Google Scholar
• Brito-Zerón P, Izmirly PM, Ramos-Casals M, et al. The clinical spectrum of autoimmune congenital heart block. Nat Rev Rheumatol. 2015;11:301–312.
   PubMed Web of Science ®Google Scholar
• Götestam Skorpen C, Hoeltzenbein M, Tincani A, et al. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis. 2016;75:795–810.
   PubMed Web of Science ®Google Scholar